Metronidazole (local route only) updated on 01-29-2025

All congenital malformations (majors, minors, majors and minors, or unspecified)

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S17611
R74371		 Kazy - Metronidazole, 2005 Congenital abnormalities (NOS) 1st trimester case control unexposed (general population or NOS) Adjustment: Yes Route of exposure Azoles: Vaginal 1.10 [0.80;1.50] 70/168   22,773/60,826 22,843 168
ref
Total 1 studies 1.10 [0.80;1.51] 22,843 168
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Kazy - Metronidazole, 2005Kazy - Metronidazole, 2005 1.10[0.80; 1.50]22,8431680%ROB confusion: unclearROB selection: criticalROB classification: moderateROB missing: lowROB mesure: unclearROB reporting: moderate0.55.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 0 case control studiescase control studies 1.10[0.80; 1.51]22,843168 -NAKazy - Metronidazole, 2005 1 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.10[0.80; 1.51]22,843168 -NAKazy - Metronidazole, 2005 1 Tags Adjustment   - Yes  - Yes 1.10[0.80; 1.51]22,843168 -NAKazy - Metronidazole, 2005 1 Route of exposure Azoles   - Vaginal  - Vaginal 1.10[0.80; 1.51]22,843168 -NAKazy - Metronidazole, 2005 1 All studiesAll studies 1.10[0.80; 1.51]22,843168 -NAKazy - Metronidazole, 2005 10.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.10[0.80; 1.51]22,843168 -NAKazy - Metronidazole, 2005 10.510.01.0